🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Lung Ground-glass Opacities

Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma NCT05528458Phase 21 site📍 Seoul Samsung Medical Center · Tests: Osimertinib 80Mg Tab Surveillance for Multifocal GGNs NCT06097910n/a1 site📍 Shanghai Fudan University · Tests: Watchful waiting Cryoablation vs Thoracoscopic Surgery for GGN NCT06848881NA1 site📍 Shanghai Shanghai Chest Hospital · Tests: Cryoablation, Thoracoscopic Surgery Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive) NCT04591002Phase 22 sites📍 Seoul📍 Seoul Samsung Medical Center · Tests: Osimertinib 80 MG
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy